Matches in Nanopublications for { ?s ?p "[The addition of palbociclib to letrozole in this phase 2 study significantly improved progression-free survival in women with advanced oestrogen receptor-positive and HER2-negative breast cancer.A phase 3 trial is currently underway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[The addition of palbociclib to letrozole in this phase 2 study significantly improved progression-free survival in women with advanced oestrogen receptor-positive and HER2-negative breast cancer.A phase 3 trial is currently underway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The addition of palbociclib to letrozole in this phase 2 study significantly improved progression-free survival in women with advanced oestrogen receptor-positive and HER2-negative breast cancer.A phase 3 trial is currently underway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1249515.RApo5glbt8yJyazIh3QclqilXgUEll6byO-eWkBHvSb3U130_assertion description "[The addition of palbociclib to letrozole in this phase 2 study significantly improved progression-free survival in women with advanced oestrogen receptor-positive and HER2-negative breast cancer.A phase 3 trial is currently underway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249515.RApo5glbt8yJyazIh3QclqilXgUEll6byO-eWkBHvSb3U130_provenance.
- NP1249518.RA0ijVOONqG2xrVEO7-hO3sUYYaTJvKIh5IQy8AjUNgZ0130_assertion description "[The addition of palbociclib to letrozole in this phase 2 study significantly improved progression-free survival in women with advanced oestrogen receptor-positive and HER2-negative breast cancer.A phase 3 trial is currently underway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249518.RA0ijVOONqG2xrVEO7-hO3sUYYaTJvKIh5IQy8AjUNgZ0130_provenance.